Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXCALIBUR: SBRT for Rising PSA After Radical Prostatectomy
NCT04915508Phase 2Active, not recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jun 2021
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoints: Change of Expanded Prostate Cancer Index (EPIC) score for the gastrointestinal domain at 2 years and Change of Expanded Prostate Cancer Index (EPIC) score for the genitourinary domain at 2 years. Started Jun 2021; status: active, not recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04915508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04915508.